Literature DB >> 8950416

Eye tracking dysfunction is a putative phenotypic susceptibility marker of schizophrenia and maps to a locus on chromosome 6p in families with multiple occurrence of the disease.

V Arolt1, R Lencer, A Nolte, B Müller-Myhsok, S Purmann, M Schürmann, J Leutelt, M Pinnow, E Schwinger.   

Abstract

The difficulties in defining the borders of the schizophrenia spectrum is one major source of variance in linkage studies of schizophrenia. The employment of biological markers may prove advantageous. Due to empirical evidence, eye tracking dysfunction (ETD) has been discussed to be the most promising marker for genetic liability to schizophrenia. With respect to the recent progress in genomic scans, which have pointed to the short arm of chromosome 6, we carried out a scan of the 6p21-23 region with 16 microsatellite markers to test for linkage between chromosomal markers and ETD as well as schizophrenia. We tested 5 models of inheritance of ETD and found maximum two-point lod scores of 3.51 for D6S271 and 3.44 for D6S282. By including these markers in a multipoint analysis, a lod score of 4.02 was obtained. In the case of schizophrenia, 7 models were tested; however, with non-significant results. Our findings, together with another recent linkage report, point to the possibility of a second susceptibility locus for schizophrenia which may be located centromeric to the HLA region. Also, the evidence of ETD being a susceptibility marker for schizophrenia receives further support.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8950416     DOI: 10.1002/(SICI)1096-8628(19961122)67:6<564::AID-AJMG10>3.0.CO;2-R

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  33 in total

1.  Replication of linkage studies of complex traits: an examination of variation in location estimates.

Authors:  S B Roberts; C J MacLean; M C Neale; L J Eaves; K S Kendler
Journal:  Am J Hum Genet       Date:  1999-09       Impact factor: 11.025

Review 2.  The genetics of schizophrenia.

Authors:  M T Tsuang; W S Stone; S V Faraone
Journal:  Curr Psychiatry Rep       Date:  1999-10       Impact factor: 5.285

3.  The future of psychiatric genetics.

Authors:  M T Tsuang; S V Faraone
Journal:  Curr Psychiatry Rep       Date:  2000-04       Impact factor: 5.285

Review 4.  Recent advances in the genetics of schizophrenia.

Authors:  D M Waterwort; A S Bassett; L M Brzustowicz
Journal:  Cell Mol Life Sci       Date:  2002-02       Impact factor: 9.261

Review 5.  The concept of FDG-PET endophenotype in Alzheimer's disease.

Authors:  Emmanuel H During; R S Osorio; F M Elahi; L Mosconi; M J de Leon
Journal:  Neurol Sci       Date:  2011-06-01       Impact factor: 3.307

6.  Biological phenotypes and genetic research on schizophrenia.

Authors:  Daniel R Weinberger
Journal:  World Psychiatry       Date:  2002-02       Impact factor: 49.548

Review 7.  Eye tracking dysfunction in schizophrenia: characterization and pathophysiology.

Authors:  Deborah L Levy; Anne B Sereno; Diane C Gooding; Gilllian A O'Driscoll
Journal:  Curr Top Behav Neurosci       Date:  2010

8.  Pursuit eye movements as an intermediate phenotype across psychotic disorders: Evidence from the B-SNIP study.

Authors:  Rebekka Lencer; Andreas Sprenger; James L Reilly; Jennifer E McDowell; Leah H Rubin; Judith A Badner; Matcheri S Keshavan; Godfrey D Pearlson; Carol A Tamminga; Elliot S Gershon; Brett A Clementz; John A Sweeney
Journal:  Schizophr Res       Date:  2015-10-23       Impact factor: 4.939

9.  Trait vs. State Markers for Schizophrenia: Identification and Characterization through Visual Processes.

Authors:  Yue Chen; L Cinnamon Bidwell; Daniel Norton
Journal:  Curr Psychiatry Rev       Date:  2006-11

10.  Neuregulin-1 genotypes and eye movements in schizophrenia.

Authors:  H Magnus Haraldsson; Ulrich Ettinger; Brynja B Magnusdottir; Andres Ingason; Samuel B Hutton; Thordur Sigmundsson; Engilbert Sigurdsson; Hannes Petursson
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-07-03       Impact factor: 5.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.